Esophageal Cancer Awareness: Gastrosophageal Reflux, Cancer & More
The incidence of esophageal adenocarcinoma has increased dramatically in the past three decades. Known risk factors include chronic gastrosophageal reflux, Barrett's esophagus, a high body mass index, and smoking. Significant advances have been made in the treatment of Barrett's esophagus and in every stage of esophageal adenocarcinoma.
As part of Esophageal Cancer Awareness Month in April, our experts discuss gastrosophageal reflux, Barrett's esophagus, screening, and various esophageal cancer treatments. Mohammad Al-Haddad, M.D., professor of medicine and division chief of gastroenterology at IU School of Medicine, is world renowned in gastrointestinal diseases and endosonography. Shadia Jalal, M.D., associate professor of medicine and the Lawrence H. Einhorn Scholar in Oncology, leads the esophageal cancer program at the cancer center and has led multiple clinical trials for that cancer type.
Tarah Ballinger, M.D., assistant professor of clinical medicine and associate director of supportive oncology, moderates.
